Evidence map›Paper›PMID 26762409›Full record

ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2016

Secretome profiling of oral squamous cell carcinoma-associated fibroblasts reveals organization and disassembly of extracellular matrix and collagen metabolic process signatures.

Elizabete Bagordakis, Iris Sawazaki-Calone, Carolina Carneiro Soares Macedo, Carolina M Carnielli, Carine Ervolino de Oliveira, Priscila Campioni Rodrigues, Ana Lucia C A Rangel, Jean Nunes Dos Santos, Juha Risteli, Edgard Graner and 3 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 4 pooled it
8.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 4 syntheses or guidelines pooled it, 80 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Elizabete BagordakisDepartment of Oral Diagnosis, School of Dentistry, State University of Campinas, Av. Limeira 901, CEP 13414-018, Piracicaba, SP, Brazil.
Iris Sawazaki-CaloneOral Pathology and Oral Medicine, Dentistry School, Western Paraná State University, Cascavel, PR, Brazil.
Carolina Carneiro Soares MacedoDepartment of Oral Diagnosis, School of Dentistry, State University of Campinas, Av. Limeira 901, CEP 13414-018, Piracicaba, SP, Brazil.
Carolina M CarnielliBrazilian Biociences National Laboratory-CNPEM, CEP 13083-970, Campinas, SP, Brazil.
Carine Ervolino de OliveiraDepartment of Oral Diagnosis, School of Dentistry, State University of Campinas, Av. Limeira 901, CEP 13414-018, Piracicaba, SP, Brazil.
Priscila Campioni RodriguesDepartment of Oral Diagnosis, School of Dentistry, State University of Campinas, Av. Limeira 901, CEP 13414-018, Piracicaba, SP, Brazil.
Ana Lucia C A RangelOral Pathology and Oral Medicine, Dentistry School, Western Paraná State University, Cascavel, PR, Brazil.
Jean Nunes Dos SantosLaboratory of Surgical Pathology, Dental School, Federal University of Bahia-UFBA, Salvador, BA, Brazil.
Juha RisteliCancer and Translational Medicine Research Unit, University of Oulu, Oulu, Finland.
Edgard GranerDepartment of Oral Diagnosis, School of Dentistry, State University of Campinas, Av. Limeira 901, CEP 13414-018, Piracicaba, SP, Brazil.
Tuula SaloCancer and Translational Medicine Research Unit, University of Oulu, Oulu, Finland.
Adriana Franco Paes LemeBrazilian Biociences National Laboratory-CNPEM, CEP 13083-970, Campinas, SP, Brazil. adriana.paesleme@lnbio.cnpem.br.
Ricardo D ColettaDepartment of Oral Diagnosis, School of Dentistry, State University of Campinas, Av. Limeira 901, CEP 13414-018, Piracicaba, SP, Brazil. coletta@fop.unicamp.br.
Universidade Estadual de Campinas (UNICAMP) · BRBrazilian Biosciences National Laboratory · BRUniversidade Estadual do Oeste do Paraná · BROulu University Hospital · FIUniversidade Federal da Bahia · BRUniversity of Oulu · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An important role has been attributed to cancer-associated fibroblasts (CAFs) in the tumorigenesis of oral squamous cell carcinoma (OSCC), the most common tumor of the oral cavity. Previous studies demonstrated that CAF-secreted molecules promote the proliferation and invasion of OSCC cells, inducing a more aggressive phenotype. In this study, we searched for differences in the secretome of CAFs and normal oral fibroblasts (NOF) using mass spectrometry-based proteomics and biological network analysis. Comparison of the secretome profiles revealed that upregulated proteins involved mainly in extracellular matrix organization and disassembly and collagen metabolism. Among the upregulated proteins were fibronectin type III domain-containing 1 (FNDC1), serpin peptidase inhibitor type 1 (SERPINE1), and stanniocalcin 2 (STC2), the upregulation of which was validated by quantitative PCR and ELISA in an independent set of CAF cell lines. The transition of transforming growth factor beta 1 (TGF-β1)-mediating NOFs into CAFs was accompanied by significant upregulation of FNDC1, SERPINE1, and STC2, confirming the participation of these proteins in the CAF-derived secretome. Type I collagen, the main constituent of the connective tissue, was also associated with several upregulated biological processes. The immunoexpression of type I collagen N-terminal propeptide (PINP) was significantly correlated in vivo with CAFs in the tumor front and was associated with significantly shortened survival of OSCC patients. Presence of CAFs in the tumor stroma was also an independent prognostic factor for OSCC disease-free survival. These results demonstrate the value of secretome profiling for evaluating the role of CAFs in the tumor microenvironment and identify potential novel therapeutic targets such as FNDC1, SERPINE1, and STC2. Furthermore, type I collagen expression by CAFs, represented by PINP levels, may be a prognostic marker of OSCC outcome.

Indexed as

Carcinoma, Squamous CellCell LineCell Line, TumorCollagen Type IDisease-Free SurvivalExtracellular MatrixFemaleFibroblastsGlycoproteinsHumansIntercellular Signaling Peptides and ProteinsMaleMouth NeoplasmsNeoplasm ProteinsPeptide FragmentsPlasminogen Activator Inhibitor 1Collagen Type IFNDC1 protein, humanGlycoproteinsIntercellular Signaling Peptides and ProteinsNeoplasm ProteinsPeptide FragmentsPlasminogen Activator Inhibitor 1Procollagenprocollagen Type I N-terminal peptideSERPINE1 protein, humanSTC2 protein, humanTransforming Growth Factor beta1Cancer-associated fibroblastsExtracellular matrixFNDC1SecretomeSERPINE1STC2Type I collagen

Identifiers

PMID26762409
OpenAlexW2237408380

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.